Based on these findings, we propose that the celecoxib loaded theranostic nanomedicine can suppress COX-2 activity in the circulating macrophages and allow us to track the macrophages tumor infiltration dynamics by molecular imaging (19F magnetic resonance and near-infrared fluorescence). Here, PTGS2 is linked to neoplasm.